Send the following on WhatsApp
Continue to ChatI liked this article on M3 India: An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients. Have a read: https://www.m3india.in/contents/journal/an-open-label-randomized-trial-indicates-that?utm_campaign=unset&utm_medium=share&utm_source=ref_wa